Predictors of response to anti ‐IL6 monoclonal antibody therapy (siltuximab) in idiopathic multicentric Castleman disease: secondary analyses of phase II clinical trial data

British Journal of Haematology, EarlyView.

Source: British Journal of Haematology - September 11, 2018 Category: Hematology Authors: Deanna E. Morra , Sheila K. Pierson , Dustin Shilling , Sepideh Nemat , Carlos Appiani , Mary Guilfoyle , Craig Tendler , Frits van Rhee , David C. Fajgenbaum Source Type: research